NeuroOne Medical Technologies Corp (NMTC)
1.02
+0.04
(+4.08%)
USD |
NASDAQ |
Sep 27, 16:00
0.99
-0.03
(-2.94%)
After-Hours: 20:00
NeuroOne Medical Technologies Research and Development Expense (Annual): 6.941M for Sept. 30, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 6.941M |
| September 30, 2022 | 4.929M |
| September 30, 2021 | 3.925M |
| September 30, 2020 | 2.076M |
| Date | Value |
|---|---|
| September 30, 2019 | 1.529M |
| September 30, 2018 | 0.7151M |
| December 31, 2017 | 0.7353M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.529M
Minimum
2019
6.941M
Maximum
2023
3.88M
Average
3.925M
Median
2021
Research and Development Expense (Annual) Benchmarks
| SINTX Technologies Inc | 8.713M |
| Nutriband Inc | 1.960M |
| enVVeno Medical Corp | 13.58M |
| Beyond Air Inc | 24.36M |
| CVRx Inc | 11.63M |